Previous Article | Next Article 
Molecular and Cellular Biology, April 1999, p. 3039-3050, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The SKN-1 Amino-Terminal Arm Is a DNA
Specificity Segment
Thiphaphone
Kophengnavong,
Adam S.
Carroll, and
T. Keith
Blackwell*
Center for Blood Research and Department of
Pathology, Harvard Medical School, Boston, Massachusetts 02115
Received 6 August 1998/Returned for modification 21 September
1998/Accepted 14 January 1999
 |
ABSTRACT |
The Caenorhabditis elegans SKN-1 protein binds DNA
through a basic region like those of bZIP proteins and through a
flexible amino-terminal arm segment similar to those with which
numerous helix-turn-helix proteins bind to bases in the minor groove. A recent X-ray crystallographic structure suggests that the SKN-1 amino-terminal arm provides only nonspecific DNA binding. In this study, however, we demonstrate that this segment mediates recognition of an AT-rich element that is part of the preferred SKN-1 binding site
and thereby significantly increases the sequence specificity with which SKN-1 binds DNA. Mutagenesis experiments show that multiple
amino acid residues within the arm are involved in binding. These
residues provide binding affinity through distinct but partially redundant interactions and enhance specificity by discriminating against alternate sites. The AT-rich element minor groove is important for binding of the arm, which appears to affect DNA conformation in
this region. This conformational effect does not seem to involve DNA
bending, however, because the arm does not appear to affect a modest
DNA bend that is induced by SKN-1. The data illustrate an example of
how a small, flexible protein segment can make an important
contribution to DNA binding specificity through multiple interactions
and mechanisms.
 |
INTRODUCTION |
Maternally expressed SKN-1 protein
is required for cell fate specification during the earliest embryonic
stages in Caenorhabditis elegans (3, 4). SKN-1 is
a transcription factor that binds DNA as a monomer (2). Its
unusual DNA binding domain (the Skn domain) (Fig.
1A) includes a carboxyl-terminal basic
region (BR) like those of dimeric basic-leucine zipper (bZIP) proteins
and a flexible amino-terminal arm like those with which homeodomains and other helix-turn-helix proteins bind in the minor groove
(2). The consensus-preferred SKN-1 binding site, as
determined by in vitro selection, consists of an AT-rich element
(A/TA/TT) immediately 5' of the sequence G/ATCAT (2), which
corresponds to the GTCAT half-site recognized by many bZIP protein BRs
(2, 32). Although individual BR peptides do not bind DNA
stably as monomers, the purified Skn domain binds to a preferred site
with a dissociation constant (Kd) in the range
of 10
9 M (8). The Skn domain BR is stabilized
on the G/ATCAT sequence primarily by the adjacent
-helical support
segment (Fig. 1A and B), which is unrelated to either a ZIP segment or
a helix-turn-helix motif and forms a globule that leaves the BR exposed
in the major groove (8, 26, 32). The Skn domain
amino-terminal arm, which is almost identical in sequence to that of
the antennapedia homeodomain (Fig. 1A), is also important for binding
affinity and has been proposed to mediate specific recognition of this AT-rich element (2, 8).



View larger version (108K):
[in this window]
[in a new window]
|
FIG. 1.
Skn domain and its interactions with DNA. (A) Diagram of
the Skn domain, which consists of the carboxyl-terminal 85 amino acids
(aa) of SKN-1 (residues 449 to 533) and is numbered as described in
reference 2. The sequences of the amino-terminal arm
and BR are compared with the corresponding sequences from the indicated
homeodomain and bZIP proteins, respectively. The four support segment
-helices identified by nuclear magnetic resonance and X-ray
crystallography (8, 26, 32) are labeled H1 to H4. The arm
and BR residues that are designated by open and filled circles contact
DNA bases and the backbone, respectively, in the Skn domain structure
determined by X-ray crystallography (32). Arg 9 in the
amino-terminal arm (SKN-1 residue 457) is shaded because it is highly
conserved in homeodomains, where it is designated position 5 (34). Sequences are from references 8 and
34. (B) Results of biochemical analyses of Skn
domain DNA binding. The BR -helix extends into the major groove
directly from support segment helix 4. Black circles indicate positions
of maximum hydroxyl radical protection by both the Skn domain and
1-9. Shaded ovals indicate where protection by the Skn domain is
greater than by 1-9, with the size of the oval indicating the
extent of difference (8). Black vertical arrows indicate
where prior hydroxyl radical cleavage enhances Skn domain binding
(8). Black arrowheads indicate positions at which adenine
methylation binding interference is greater for the Skn domain (Fig.
4). The small shaded arrow in the minor groove indicates the
approximate direction that corresponds to the amino terminus of a
homeodomain arm, relative to the location of the major groove
recognition helix. The wide downward-pointing arrow indicates the
approximate position at which the major groove corresponds to the
direction in which the Skn domain and 1-9 bend DNA. (C) Structure
of the Skn domain bound to DNA (32). The Skn domain backbone
is shown in blue, along with the Arg 9 (Arg 457) side chain. Other side
chains are not shown because they are not positioned close to the
AT-rich region (32). The DNA backbone is orange, the GTCAT
base pairs are yellow, and the AT-rich region bases are red. Green
spheres indicate the sugar residues protected from hydroxyl radical
attack specifically by the amino-terminal arm (Fig. 1B). Residues that
are located amino terminal to Gly 8 (Gly 456) are disordered and not
visible in the structure (32).
|
|
However, the recent crystal structure of an Skn domain-DNA complex does
not support the idea that the amino-terminal arm contributes to binding
sequence specificity (32). This structure (Fig. 1C) was
determined with a preferred SKN-1 DNA binding site (2) and
an Skn domain derivative in which a tag of six histidine (His) residues
was attached immediately amino terminal to the arm at position 2 (Fig.
1A) (32). The crystal structure is generally consistent with
mutagenesis, footprinting, and nuclear magnetic resonance spectroscopic
data with respect to how the support segment stabilizes the BR on DNA
(32). However, this structure does not suggest a mechanism
for how the amino-terminal arm might mediate any base sequence
preferences. It indicates that the amino terminus of the arm points
away from the support segment (Fig. 1C) (32) in an
orientation opposite to that of most helix-turn-helix protein arm
segments (Fig. 1B), which usually lie within the minor groove and
contact bases and the adjacent DNA backbone (1, 10, 14, 17-19,
23, 43, 44). In this structure, the Skn domain arm does not
interact with the DNA minor groove and appears to make only a single
direct contact with the backbone (Fig. 1C) (32). Based upon
these findings, it has been concluded that the similarity of the SKN-1
amino-terminal arm segment to homeodomain arms (Fig. 1A) derives simply
from a clustering of basic residues, that this segment contributes only
nonspecific DNA binding affinity, and that the SKN-1 binding site
consists only of G/ATCAT (32).
For multiple reasons, it is important to elucidate how the
amino-terminal arm contributes to SKN-1 DNA binding. It is of interest to determine whether the arm increases the number of bases specified by
SKN-1, because we have only a limited understanding of which target
genes SKN-1 might regulate in vivo (49). In addition, homeodomain arm segments can be bound by protein cofactors (41, 43, 48) and are critical for functional specificity that is not
directly attributable to DNA binding (11, 22, 24, 47), suggesting that the Skn domain arm might be involved in similar interactions. Finally, it is of importance to identify general principles by which such small peptide segments can contribute to DNA
binding affinity and specificity.
In this study, we demonstrate that the Skn domain amino-terminal arm
increases binding specificity significantly by conferring a sequence
preference for the AT-rich element. Multiple amino acid residues within
the arm appear to interact with the DNA but are not individually
essential for binding affinity, suggesting conformational flexibility.
A conserved arginine (Arg 9) (Fig. 1A and C) appears to be the most
important of the basic residues within the arm, but each of them
contributes specificity by destabilizing binding to nonpreferred sites.
A glycine that is interspersed among these basic residues (Gly 8)
influences interaction of the entire arm with the DNA (Fig. 1A and C)
and may contact DNA directly. Binding of the arm appears to depend upon
the AT-rich region minor groove and to influence DNA conformation. This
conformational effect does not seem to involve DNA bending, however,
because binding of the arm does not substantially influence a modest
DNA bend (<10°) that is mediated by the BR and support segment.
These experiments demonstrate that the Skn domain amino-terminal arm, like those of helix-turn-helix proteins, is an important DNA
specificity segment and that it establishes these sequence preferences
through multiple interactions. The results of these experiments also
suggest a model for how this small protein segment binds to the DNA.
 |
MATERIALS AND METHODS |
Protein expression and DNA binding assays.
The Skn domain
protein and a mutant protein that lacks the arm (amino acids 1 to 9) of
the Skn domain (
1-9) were expressed in Escherichia coli,
purified, and quantitated by spectroscopic and amino acid analysis as
described in reference 8. Expression and
purification of the glutathione S-transferase-SKN-1 protein were described previously (2). Kds
were determined at room temperature by electrophoretic mobility shift
assay (EMSA) under conditions of protein excess as described previously
(8), except that only siliconized tips and tubes were used.
The Kd with which the Skn domain binds its
preferred site had been measured as 1 (±0.5) × 10
9 M
(8), but under these latter conditions this
Kd was approximately 3 × 10
10 M.
Deletion mutations were produced by PCR and confirmed by DNA
sequencing. Substitution mutations were constructed by the
circular-mutagenesis
change reaction (
45). Expression and
quantitation of in vitro-translated
proteins were performed essentially
as described in reference
8 with a combined
transcription-translation kit (Promega).
Each protein was quantitated
multiple times by
35S-labeled translation and sodium
dodecyl sulfate-polyacrylamide
gel electrophoresis. The variability
among these translations
generally fell within a range of 1.5-fold.
EMSAs were performed
as described previously (
8), with
poly(dI-dC) present at 0.0125
µg/µl in each sample. Each protein
was tested as described in
the legend to Fig.
2 with at least two
different preparations
of unlabeled protein to ensure
reproducibility.
The DNA probe and procedures used in the methylation interference assay
have been described previously (
2). To ensure that
the
observed effects were reproducible and derived from specific
binding,
each experiment was performed multiple times under conditions
at which
an EMSA (not shown) demonstrated that 10 to 50% of the
input DNA was
in the bound fraction and that only a single protein
molecule was
bound.
Circular-permutation assay.
Probes for the
circular-permutation assay were constructed from a Bluescript plasmid
containing an in vitro-selected SKN-1 binding sequence that includes
the ATTGTCAT preferred binding site (2). Three
different sets of PCR primers were used to generate probes A, B, and C,
which were each 160 bp in length. In probe A, the SKN-1 binding site
was 12 bp from the 5' end; in probe B, it was 77 bp from the 5' end;
and in probe C, it was 10 bp from the 3' end. The probes were purified
and end labeled with 32P by polynucleotide kinase. The EMSA
was performed on 6% polyacrylamide gels as described in reference
2, with the Skn domain protein,
1-9, and
full-length SKN-1 present at concentrations of 1, 30, and 50 nM, respectively.
Ligation-mediated cyclization kinetics assay.
The
cyclization kinetics assay was performed essentially as described by
Kahn and Crothers (15). Ligation substrates were constructed
with plasmids (31 and 37 pBluescript II KS 11T15F) (15, 27)
that were gifts of David Fisher. Each contained a Max protein binding
site located 31 or 37 bp from a sequence of six regularly spaced
poly(dA) tracts, which induces an intrinsic bend. The Max binding sites
were replaced by a single preferred SKN-1 binding site, which was
placed at different positions by PCR. These plasmids were used to
generate the cyclization probes (SK32 to SK41) listed in Table
1, as described previously
(27).
To establish protein concentrations that were ideal for complete and
specific binding to these cyclization probes, EMSAs were
performed
under the conditions that were used for ligation (see
below).
Nonspecific binding was assayed by performing side-by-side
EMSAs with
minicircle substrate identical to the substrate used
in the
above-described assays except that it lacked an SKN-1 binding
site
(
27). The Skn domain concentrations chosen for the ligation
experiments varied between 10 and 25 nM (not corrected for activity),
depending upon the protein preparation. However, under these
conditions,
the levels of specific and nonspecific binding by

1-9
differed
by only 1 order of magnitude at room temperature, making it
advantageous
to perform these experiments at 0°C, which stabilized
specific
binding (not shown). The

1-9 concentrations then chosen
for ligation
experiments ranged between 50 and 125 nM (not corrected
for activity),
also depending upon the protein stock. Under these
conditions,
a nonspecific probe was not bound appreciably by either the
Skn
domain or

1-9 and the bulk of specific probe was bound by a
single
protein molecule (not
shown).
Cyclization kinetics assays were performed at a DNA concentration of
3 × 10
11 M, as described previously
(
27), except that 0.1% Nonidet P-40
was added. Experiments
involving

1-9 were performed at 0°C, and
those involving the Skn
domain were performed at room temperature,
but the latter results were
confirmed at 0°C (not shown). Each
ligation reaction mixture
contained DNA at a concentration of
32 pM. Reaction mixtures were
incubated for 30 min, and then cyclizations
were initiated by the
addition of 50 to 1,000 U of ligase. At
10 different time points, 16 µl of the reaction mixture was removed
and the ligation was halted by
the addition of 8 µl of the proteinase
K mixture described in
reference
15. By varying the amount of
ligase added,
these experiments were performed over times ranging
between 4 and
21 h. Reaction mixtures were heated and then analyzed
in a 6%
native gel as described previously (
15). Dried gels
were
analyzed by PhosphorImaging (Molecular
Dynamics).
 |
RESULTS |
The amino-terminal arm specifies the AT-rich element.
To
determine whether the AT-rich element that was selected in vitro
(2) is important for high-affinity binding, we assayed binding of the Skn domain to an oligonucleotide (SK1) (Fig. 2A and
B, lanes 1 to 5) that matches the
preferred consensus (2) and to an otherwise identical site
in which the AT-rich element had been changed to GCC (
3,
2,
1 GCC)
(Fig. 2A and B, lanes 11 to 15). The purified Skn domain (8)
bound to SK1 with an approximately fivefold higher affinity than it
bound to the
3,
2,
1 GCC site (not shown), as indicated by
titration in an EMSA in which the Kd was
estimated from the protein concentration that binds 50% of the input
DNA (6).

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 2.
Involvement of the Skn domain amino-terminal arm in DNA
binding affinity and specificity. (A) Binding of the Skn domain and the
1-9 Skn domain mutant (2) to DNA, assayed by EMSA at
room temperature (RT). The ATTGTCAT preferred site assayed
is the 22-bp oligonucleotide SK1 (2). The GCCGTCAT
mutant site ( 3, 2, 1 GC [2]) is identical to
SK1 except for these three base pairs. Protein concentrations are
indicated above the gel (in 10 12 molar units), and
specific DNA is present at 5 × 10 12 M. (B) Binding
of the Skn domain and the 1-9 mutant to the SK1 and 3, 2, 1 GC
sites at 0°C, assayed as described for panel A.
|
|
We also tested binding of the Skn domain to these sites by EMSA
titration of in vitro-translated protein, performed at a low
concentration (5 × 10
12 M) of specific DNA to
obtain a semiquantitative measurement of
binding. These conditions may
be more similar to those of a cellular
environment than are those of
assays of binding by a purified
protein, because both reticulocyte
lysate proteins and poly(dI-dC)
competitor are present. In this assay,
the in vitro-translated
Skn domain appeared to bind the SK1 site with a
moderately higher
affinity than was measured previously for the
purified Skn domain
(Fig.
2A, lanes 1 to 5) (see Materials and
Methods). Significantly,
a >100-fold-higher concentration of the Skn
domain protein was
required to bind

3,

2,

1 GCC at a level
comparable to that at
which it bound the preferred site, SK1 (Fig.
2A,
lanes 5 and 11),
demonstrating that the AT-rich element is an important
part of
the high-affinity consensus SKN-1 binding
site.
To determine whether the amino-terminal arm segment is involved in this
sequence specificity, we assayed binding to these
sites of an Skn
domain mutant that lacks the arm (

1-9) (Fig.
1A) (
2). In
an assay performed with purified proteins at room
temperature, the Skn
domain protein bound SK1 at a fivefold higher
affinity than did

1-9
(
8). However, binding by in vitro-translated

1-9 was
detectable only at 0°C (Fig.
2A and B, lanes 6). In the
latter assay,
the concentrations of the Skn domain protein and

1-9 that gave
similar levels of SK1 binding differed by about
2 orders of magnitude
(Fig.
2B, lanes 5 and 6). In contrast, these
proteins bound at
comparable levels to the

3,

2,

1 GCC mutant
site (Fig.
2B, lanes 11 to 20), and

1-9 bound as well to this
site as to SK1 (Fig.
2B,
lanes 6 to 10 and 16 to 20), demonstrating
that the specificity of the
Skn domain for the AT-rich element
is mediated by the amino-terminal
arm.
Multiple Skn domain amino-terminal arm residues contribute to DNA
binding affinity and specificity.
In most homeodomain
amino-terminal arms, except for those in yeast proteins such as
2
(Fig. 3A), the Arg residue that
corresponds to Skn domain Arg 9 is conserved and lies carboxyl terminal
to a residue that varies according to protein class but is often Gly or
Pro (Fig. 1A and 3A) (34). The more distal arm residues (positions 5 to 7) are usually basic but are less conserved (Fig. 1A
and 3A) (34). To investigate how these individual residues contribute to Skn domain DNA binding, we created mutations in the arm
that included amino-terminal deletions and alanine substitutions to
replace individual side chains with a methyl group (Fig. 3A) and tested
their abilities to bind to the SK1 and
3,
2,
1 GCC sites. In the
EMSA, a low temperature noticeably stabilizes binding that involves
either the
1-9 mutant protein or the
3,
2,
1 GCC mutant DNA
sequence (Fig. 2A and B, lanes 5 to 20) but not specific binding of the
Skn domain to the optimal sequence, SK1, as indicated by comparison of
the bound and free DNA fractions (Fig. 2A and B, lanes 1 to 5). Binding
by various other mutant proteins and DNA sequences that we have
analyzed was also relatively enhanced at low temperature (see below),
presumably because these mutant protein-DNA complexes are less stable.
We therefore tested these mutants for binding at both room temperature
and 0°C to allow their binding to be compared stringently with
optimal Skn domain-DNA binding and still permit analysis of weak
mutants such as
1-9.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 3.
Mutational analysis of the Skn domain amino-terminal
arm. (A) Mutations constructed within the arm, which is compared with
homeodomain arm segments. In each of these proteins, the amino-terminal
arm was altered as shown, but the remainder of the Skn domain (Fig. 1)
was intact. Each sequence is preceded by an initiation methionine. Open
and closed circles indicate contacts with bases and the backbone,
respectively, that were revealed by structural studies (1, 17, 23,
32). (B) Binding of the indicated proteins (described in panel A)
to the SK1 oligonucleotide site (Fig. 2). Equal concentrations (25 pM)
of these in vitro-translated proteins were assayed for DNA binding at
room temperature (RT) by EMSA. Only the preferred sequence is shown
below the gel, with the AT-rich region being shaded. (C) EMSA carried
out as described for panel B but performed at 0°C. (D) EMSA of the
indicated proteins for binding to the 3, 2, 1 GC mutant site (Fig.
2) at room temperature. (E) EMSA carried out as described for panel D
but performed at 0°C.
|
|
The deletion mutants

1-4 and

1-7 (Fig.
3A) both bound well to
SK1 (Fig.
3B, lanes 8 and 9), and an EMSA titration indicated
that

1-7 and the Skn domain bound to this site with very similar
affinities (Fig.
4A, lanes 1 to 10),
indicating that the more
distal (amino-terminal) residues in the arm
(positions 1 to 7)
(Fig.
3A) are not required for binding affinity. In
contrast,
the dramatic difference in levels of binding between

1-9
and

1-7 (Fig.
2A and
4A, lanes 6 to 10, and 3B and C, lanes 9 and
12) suggests that residues 8 and 9 are particularly important.
This
finding is consistent with the Skn domain crystal structure,
in which
Arg 9 appears to contact the DNA directly (Fig.
1C) (
32).

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 4.
EMSA titration of DNA binding by Skn domain
amino-terminal arm mutants. (A) Binding of the Skn domain and 1-7
proteins (Fig. 3A) to the indicated sites, assayed at room temperature
(RT) as described for Fig. 2. Protein concentrations are indicated
above the gel (in 10 12 molar units), and specific DNA was
present at 5 × 10 12 M. (B) EMSA carried out as
described for panel A but performed at 0°C. (C) Binding of the 9R-A
and 1-7 9R-A proteins (Fig. 3A) to the indicated sites, assayed as
described for panel A. (D) EMSA carried out as described for panel C
but performed at 0°C. (E) Binding of the 8G-A and 1-7 8G-A
proteins (Fig. 3A) to the indicated DNA sequences, assayed as described
for panel A. (F) EMSA carried out as described for panel E but
performed at 0°C.
|
|
Binding to the preferred SK1 site was not affected by substitution of
Ala for basic residues 5, 6, and 7 (Fig.
3A; Fig.
3B
and C, lanes 1 and
3 to 5) but, surprisingly, was only partially
impaired by substitution
of Ala for Arg 9 (Fig.
3A; Fig.
3B and
C, lanes 1 and 7). The latter
finding was confirmed by an EMSA
titration experiment (Fig.
4A to D,
lanes 1 to 5), and it suggested
that interaction of the Skn domain arm
with DNA may be more complicated
than was indicated by the crystal
structure (Fig.
1C) (
32).
Consistent with this idea,
although deletion of residues 1 to
7 did not decrease the affinity of
the Skn domain for SK1 (Fig.
3B and C, lanes 1 and 9, and 4A and B,
lanes 1 to 10), this deletion
modestly impaired binding in the context
of the Arg 9-to-Ala substitution
(Fig.
3B and C, lanes 7 and 11, and 4C
and D, lanes 1 to 10),
suggesting that the more distal basic residues
can contribute
affinity. Given these results, it appears likely that
multiple
basic residues in the Skn domain arm can interact with DNA but
that they are partially redundant for binding. In addition, replacement
of Gln 4 with Arg (4Q-R) inhibited binding (Fig.
3B and C, lanes
2),
suggesting that this even more amino-terminal residue may
also be
located close to the
DNA.
To evaluate how individual residues in the arm contribute to sequence
specificity, we assayed binding of these mutants to
the

3,

2,

1 GCC
site (Fig.
3D and E). Although the Arg 9-to-Ala
substitution (Fig.
3A)
decreased binding of the Skn domain to
SK1 (see above), surprisingly,
this mutation modestly increased
its affinity for

3,

2,

1 GCC (Fig.
3B to E, lanes 1 and 7, and
4A to D, lanes 1 to 5 and 11 to 15).
Supporting this idea, in
a binding site competition assay, the SK1 site
more effectively
competed binding by the Skn domain than by the 9R-A
mutant protein,
but the

3,

2,

1 GC site more effectively competed
binding by
the 9R-A mutant than by the Skn domain (Fig.
5A and
C, lanes 1,
2, 13, and 14). Surprisingly,
replacement of individual distal
basic residues (positions 5 to 7)
(Fig.
3A) with Ala comparably
enhanced binding of the Skn domain to the

3,

2,

1 GCC site (Fig.
3B to E, lanes 1 and 3 to 5). Consistent
with this finding, the

1-4 mutant retained the complete AT-rich
element preference (Fig.
3B to E, lane 8), but the

1-7 mutant bound
with higher affinity
than the Skn domain to the

3,

2,

1 GCC site
(Fig.
3D and E, lanes
1 and 9; 4A and B, lanes 1 to 20; and 5C, lanes
1, 3, 17, and
19). Simultaneous removal of these distal basic residues
(positions
1 to 7) and replacement of Arg 9 with alanine further
diminished
the relative preference for the AT-rich element (Figs.
3B to
E,
lane 11, and 4C, lanes 6 to 10 and 16 to 20), as confirmed by
binding site competition analysis (Fig.
5, lanes 4 and 8). However,
the

1-7 9R-A mutation did not impair binding as severely as did
the

1-9 deletion (Fig.
3B to E, lanes 11 and 12), a difference
that may
involve additional DNA contacts by the mutant arm (see
below) or a
stabilizing effect on the overall Skn domain fold
(
35).
Together, these experiments indicate that although individual
basic
residues in the arm are not required for binding affinity,
each
enhances specificity by diminishing binding to the GC-rich
mutant site.

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 5.
Binding site competition analysis of Skn domain
amino-terminal arm mutants. (A) Binding of the indicated in
vitro-translated proteins (Fig. 3A) to the labeled SK1 site at room
temperature, assayed as described in the legend to Fig. 3B. Protein and
labeled DNA concentrations were 45 pM and 1 nM, respectively. Unlabeled
SK1 competitor was added to binding reaction mixtures at the indicated
ratios of competitor to labeled probe. (B) EMSA of binding to the
labeled 3, 2, 1 GC mutant site, performed as described for panel A,
with unlabeled SK1 competitor added as indicated. (C) EMSA of binding
to the SK1 site, with unlabeled 3, 2, 1 GC competitor added as
indicated. (D) EMSA of binding to the 3, 2, 1 GC site, with
unlabeled 3, 2, 1 GC competitor added as indicated.
|
|
Mutagenesis experiments also indicated that Gly 8 (Fig.
3A) is
important for DNA binding. The Gly 8-to-Ala mutation significantly
impaired binding of the Skn domain to SK1, thereby diminishing
the
AT-rich preference (Fig.
3B to E, lane 6, and 4, B, E, and
F, lanes 1 to 5 and 11 to 15). In the context of the

1-7 mutant,
however, this
substitution decreased specific binding affinity
to a lesser extent
(Fig.
3B to E, lanes 6, 9, and 10, and 4A,
B, E, and F, lanes 1 to 10),
indicating that the distal arm residues
(positions 1 to 7) destabilize
binding when Gly 8 is replaced
with Ala. The last observation is in
sharp contrast to the finding
that these distal residues stabilize
binding by the 9R-A mutant
(see above). These experiments suggest that
the Gly 8-to-Ala substitution
may destabilize Skn domain DNA binding by
impairing the interaction
of the entire arm with DNA, a model that may
explain why the DNA-bound
8G-A Skn domain mutant migrates at a
relatively decreased mobility
(Fig.
3B to E, lanes 1 and 6), but they
are also consistent with
the possibility that Gly 8 contacts DNA
directly.
Binding of the amino-terminal arm at the AT-rich region.
In
the Skn domain crystal structure, the amino-terminal arm does not
interact with bases or appear to influence DNA conformation at the
AT-rich region (Fig. 1C) (32). Instead, this structure indicates that the Arg 9 amino group is located approximately 3.7 and
4.7 Å (Protein Data Bank; 1SKN) from the bottom-strand phosphates at
3 and
4, respectively (Fig. 1B and C) and that salt bridges may
occur between the arm and DNA positions further from the GTCAT
consensus (32). The Skn domain amino-terminal arm protects
DNA from hydroxyl radical cleavage around
4 on the bottom strand and
to a lesser extent at
1 and
2 on the top strand (Fig. 1B and C)
(8), suggesting that the arm lies close to the backbone, or
the minor groove, at and distal to the AT-rich region. The crystal
structure is consistent with the protection detected at
4 but does
not readily explain the remaining protection. In addition,
discrimination by the Skn domain against GCC at positions
3 through
1 is mostly relieved by replacement of these G · C pairs with
inosine (I) · C pairs (2). Inosine lacks the guanine amino group that protrudes into the minor groove; therefore I · C base pairs are indistinguishable from A · T base pairs in this
case. The last finding indicates that the AT-rich region minor groove
is important for Skn domain binding.
To investigate further how the Skn domain arm might specify the AT-rich
region, we studied how N3 methylation of adenine in
the minor groove
interferes with DNA binding by the Skn domain
protein and the

1-9
mutant. The methylation interference pattern
for the Skn domain (Fig.
6) was not appreciably different from
that of full-length SKN-1 (
2). Adenine methylation within
the
AT-rich region, especially at positions

2 and

1 on the bottom
strand, had a greater relative inhibitory effect on DNA binding
by the
Skn domain than that by

1-9 (Fig.
1B and
6; compare the
relative
levels of interference at

2,

1, and +4 on the bottom
strand). This
is similar to how, at these positions, the presence
of guanine
NH
2 groups in the minor groove interfered with binding
by
the Skn domain but not by

1-9 (see above; Fig.
2B). In contrast,
adenine methylation at

5 and positions further from the bZIP
half
site did not impair Skn domain binding (Fig.
6). These findings
further support the model that the AT-rich region minor groove
is
specifically involved in binding of the amino-terminal arm.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 6.
Methylation interference with Skn domain DNA binding. An
end-labeled and partially methylated SKN-1 binding site was bound by
the indicated purified protein (Skn domain or 1-9) and then bound
(lanes B) and free (lanes F) DNA fractions were separated by EMSA.
After cleavage, these DNA samples were run on sequencing gels, which
were analyzed with a PhosphorImager. A representative experiment is
shown. Shaded and black arrows alongside the gel indicate the AT-rich
region and bZIP half-site, respectively, with the arrow pointing
away from the center of the complete bZIP binding site. Top and bottom
indicate the DNA strands shown between the graphs on the right.
Band intensities at each position were converted to ratios of
bound-to-free DNA fractions, which were normalized to 1 at
positions at which no binding occurred, and are represented in
graphs to the right. Site positions are numbered so that 0 corresponds
to the center of a bZIP dimer site.
|
|
DNA bending associated with SKN-1 binding.
The importance of
the AT-rich region minor groove may potentially reflect direct binding
by the SKN-1 amino-terminal arm, or alternatively, this sequence may
more readily accommodate an indirect conformational effect. Consistent
with the latter model, prior hydroxyl radical cleavage next to the
AT-rich region enhanced binding of the Skn domain but not of
1-9
(Fig. 1B) (8). This observation indicates that binding of
the arm involves an energy cost which is decreased by breaking the DNA
backbone at these positions, suggesting that the arm normally
stabilizes a less favorable DNA conformation. Since A · T base
pairs allow bending towards the minor groove, it is possible that the
arm specifies the AT-rich region because it can more readily bend or
otherwise distort the DNA through this particular arrangement of base pairs.
We used the circular-permutation assay (
46) to test whether
the Skn domain protein or the

1-9 protein promotes DNA bending.
If
a protein bends DNA, the electrophoretic mobility of the protein-DNA
complex is influenced by the position of the binding site along
a
linear DNA fragment. If the binding site is in the middle of
the
fragment (probe B) (Fig.
7A), bending
will induce a more distorted
shape than if the site is at either end
(probes A and C) (Fig.
7A), resulting in a relatively slower gel
mobility. In the absence
of added protein, probes A, B, and C migrated
with indistinguishable
mobilities (Fig.
7B, lanes 1 to 3). In contrast,
complexes of
either the Skn domain,

1-9, or full-length SKN-1 with
probe B
(Fig.
7A) migrated with comparably decreased mobilities (Fig.
7B, lanes 4 to 9, and data not shown). These findings suggest
that
full-length SKN-1, the Skn domain, and

1-9 proteins may
each bend
DNA, but they should be interpreted conservatively because
the shapes
of certain DNA binding domains can cause similar gel
mobility anomalies
(
27,
36,
37).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 7.
Circular-permutation analysis of Skn domain DNA binding.
(A) Diagrams of probes A, B, and C. In each probe the SKN-1 binding
site is located at a different position relative to the ends. The
AT-rich region and bZIP half-site within the SKN-1 binding site are
indicated by a filled and open box, respectively. (B) EMSA in which the
purified proteins designated below the gel were bound to probes A, B,
and C, as indicated above the gel.
|
|
As an independent bending assay, we performed cyclization kinetics
(
15), which measures whether protein binding affects
the
rate at which DNA that contains a fixed bend can form a ligated
minicircle (Fig.
8A). Cyclization is
enhanced if a protein bends
DNA in the same direction as that of the
fixed bend and is inhibited
if the DNA is bent in the opposite
direction (
15) or held straight
(
27). The
relative kinetics of circular versus bimolecular ligation
can be
quantitated as the
J factor (Table
1), which is proportional
to the bending angle (
15). This assay also reveals the
approximate
direction of bending, because in these substrates the site
is
phased around a helical turn of DNA relative to the fixed bend
(Fig.
8A).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 8.
Cyclization kinetics analysis of DNA bending by SKN-1.
(A) Cartoon (not drawn to scale) of minicircle ligation probes in which
the SKN-1 binding site is phased along a turn of the DNA helix relative
to a fixed bend. (B) Effects of 1-9 binding on ligation of the SK36
probe. The products of a representative ligation experiment were
analyzed by electrophoresis. These products can include monomeric
circles and dimeric species, as shown. The proportion of dimers varied
among these experiments but was never greater than that apparent here
and was usually undetectable, as in panel C. The time course of
ligation is depicted above the gel and represented in the graph in
panel D. Comparable results were obtained with shorter time courses
(not shown). (C) Effects of 1-9 binding on ligation of the SK41
probe, in which the SKN-1 binding site is located 5 bp further from the
fixed bend than in SK36. A representative ligation experiment was
analyzed by electrophoresis. (D and E) Plots of the results of the
ligation experiments shown in panels B and C, respectively.
|
|
Binding of either

1-9 or the Skn domain protein inhibited
cyclization of the SK34 and SK36 substrates (Fig.
8B and D; Table
1)
but stimulated SK40 and SK41 cyclization (Fig.
8C and E; Table
1).
These effects correlated with phasing of the SKN-1 binding
site around
a DNA helical turn (10.5 bp), so that opposite effects
were observed on
opposite sides of the helix (Table
1), suggesting
that these proteins
bend DNA in similar directions. Consistent
with this idea, neither
protein affected cyclization of SK32 and
SK38 (Table
1), in which the
sites are located at intermediate
positions. The
J ratios
derived from binding of either of these
proteins to SK34 or SK36
differed from those associated with SK40
or SK41 binding by a factor of
approximately 3 (Table
1), suggesting
that they each induce a modest
DNA bend (5 to 10°) (
12,
13).
The positions of these SKN-1
binding sites relative to the fixed
bend indicate that both proteins
bend DNA approximately towards
the major groove at position +6 within
the SKN-1 binding site
(Fig.
1B). The magnitude and direction of this
DNA bend are consistent
with the 7° bend that occurs in the Skn
domain-DNA crystal structure
(
32). These experiments suggest
that the amino-terminal arm
does not significantly influence DNA
bending but leave open the
possibility that AT-rich sequence
specificity derives from a different
type of conformational
effect.
Sequence preferences of the amino-terminal arm.
To investigate
further how the amino-terminal arm might specify base recognition
within the AT-rich region, we assayed how mutations within the arm
affected binding of the Skn domain to a panel of binding site mutants.
The Skn domain and various mutant derivatives bound at higher
affinities to the
3,
2,
1 GCC mutant site than to a site in which
ATT was replaced with CGG (Fig. 9, lanes
7 to 17), indicating that its sequence specificity in this region may
be even greater than was indicated by the experiments described above.
The difference in levels of binding between these two mutant sites does
not derive entirely from the amino-terminal arm, however, because the
1-9 mutant also bound at lower affinity to the
3,
2,
1 CGG site
(Fig. 9, lanes 11 and 17). Binding by either the Skn domain or
1-7
was reduced by replacement of ATT with TAA (Fig. 9, lanes 1, 3, 19, and
21), indicating that the particular arrangement of these A · T
base pairs is important for binding. To investigate the contribution of
individual A · T base pairs, we back-substituted the
corresponding SK1 residue for each residue within the
3,
2,
1 GCC
site. Each of these substitutions enhanced binding by the Skn domain
(Fig. 9, lanes 7, 25, 31, and 37), suggesting that each base pair
normally contributes to binding. In addition, the
1-7 mutant bound
comparably to each back-substituted site, indicating that no single
A · T base pair is sufficient to restore high-level binding by
this truncated arm (Fig. 9, lanes 3, 27, 33, and 39). This last finding
is consistent with the model suggesting that binding of the arm
involves a conformational effect that depends upon each of these
positions. However, some residues within the arm may still interact
specifically with particular positions within the AT-rich element, as
was suggested by the finding that the 9R-A mutant binds at higher
affinity to the
3,
2,
1 ACC and
3,
2,
1 GTC sites than to the
3,
2,
1 GCT site (Fig. 9, lanes 26, 32, and 38).

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 9.
Binding of the Skn domain to mutant DNA sequences. Shown
are results of EMSAs at room temperature (RT) (A) and at 0°C (B) of
the indicated proteins (Fig. 3A) to determine binding to the SK1
preferred site (ATTGTCAT) or to the various mutant sites
shown, which differ from SK1 only at the indicated bases. DNA and
specific protein concentrations were 1 nM and 50 pM, respectively.
|
|
 |
DISCUSSION |
Multiple amino-terminal arm residues contribute to SKN-1 DNA
binding specificity.
We have demonstrated that an AT-rich element
adjacent to the bZIP half-site is important for high-affinity DNA
binding by the Skn domain and that this sequence specificity is
mediated almost exclusively by the amino-terminal arm (Fig. 2),
although the remainder of the Skn domain may have a minor influence
(Fig. 9, lanes 5, 11, and 17). Each base pair within the AT-rich
element contributes to this specificity, and variations within this
sequence can result in a range of binding affinities (Fig. 9). In light of previous experiments, which have indicated that the preferences of
the Skn domain and full-length SKN-1 for the AT-rich element are
comparable (2), our findings suggest that this sequence element is likely to be relevant to SKN-1 function in vivo.
Site-directed mutagenesis experiments showed that individual residues
within the Skn domain amino-terminal arm make distinct
contributions to
DNA binding affinity and specificity, particularly
at room temperature
(Fig.
3 and
4). Replacement of Arg 9 decreases
binding affinity,
especially when the distal arm residues (positions
1 to 7) are deleted,
and diminishes the AT-rich preference further
by enhancing
binding to the

3,

2,

1 GCC site (Fig.
3B to E, lanes
1, 7, 9, and 11; Fig.
4 and
5). The Skn domain structure predicts
that Arg 9 is
likely to be important, because it suggests that
this residue contacts
DNA directly (Fig.
1C) (
32). However,
replacement of Gly 8 within the Skn domain even more markedly
impairs binding (Fig.
3B to E,
lanes 1, 6, and 7; Fig.
4), even
though this residue does not contact
DNA in the crystal structure
(Fig.
1C) (
32). Gly 8 is less
critical for binding affinity
when residues 1 to 7 are removed (Fig.
3B
to E, lanes 1, 6, and
10, and 4E and F), indicating that it might
provide the rotational
flexibility required for proper positioning of
these residues.
In addition, contacts between glycine residues and
nucleic acids
have been observed (
10,
23,
31), suggesting
that Gly 8 may
also interact directly with the DNA. The distal basic
residues
in the arm (positions 5 to 7) (Fig.
3A) are disordered in the
Skn domain structure (Fig.
1C) (
32) and not required for
binding
affinity (Fig.
3B, lane 9; Fig.
4), but individual Ala
substitutions
at these positions each diminish the AT-rich preference
(Fig.
3B to E, lanes 3 to 5). In addition, residues 1 to 7 stabilize
binding by the 9R-A mutant (Fig.
3B to E, lanes 7 and 11; Fig.
4 and
5), indicating that they can make otherwise redundant contributions
to
binding affinity. These last observations suggest that residues
5 to 7 can contribute to DNA binding, presumably through heterogeneous
or
unstable interactions. The distinct functions of these different
Skn
domain arm residues indicate that this segment does not represent
simply a random collection of basic residues. However, the functional
significance of its similarity to homeodomain arms (Fig.
1A) remains
to
be
determined.
The finding that alanine substitution for any basic residue in the Skn
domain arm enhances binding to the

3,

2,

1 GC mutant
site (Fig.
3B
to E) suggests that these residues interact with
DNA more readily if
the AT-rich element is present and destabilize
the protein-DNA complex
if they are not bound to the DNA. This
effect may contribute to
destabilization of 8G-A DNA binding by
residues 1 to 7 (Fig.
3B to E,
lanes 6 and 10) and may involve
not only steric incompatibility but
also their highly basic charge.
For example, basic DNA binding regions
related to the Skn domain
BR have an intrinsic

-helical character
(
20,
33,
42) but
form an

-helix only upon DNA binding
(see reference
8), presumably
because they require
some neutralization of positive charges.
Similarly, the SKN-1-DNA
complex may potentially be destabilized
if the amino-terminal arm
cannot properly engage a nonpreferred
site and if its basic charges are
not at least partially neutralized.
This mechanism might have
contributed to destabilization of binding
by introduction of an Arg
residue at position 4 (4Q-R) (Fig.
3B
to E, lanes 2), at which an
initiation methionine is tolerated
(

1-4) (Fig.
3B and D, lanes
8).
The DNA sequence specificity of protein-DNA binding is generally
understood to involve hydrogen bonding and van der Waals
interactions
that contribute affinity, and numerous examples of
how individual amino
acid residues can bind to particular bases
have been described
(
29,
39). Specificity can also be profoundly
influenced by
intrinsic DNA structure (
30) and by how well the
protein and
DNA adapt to each other (
38). Our findings suggest
an
additional mechanism, in which residues that do not necessarily
contribute affinity can enhance binding specificity by inhibiting
interactions with nonpreferred DNA sequences. Presumably, such
residues
destabilize the overall interaction if they are not properly
engaged in the binding surface. This mechanism of energetic exclusion
can narrow the field of potentially favorable binding sites that
are
specified on the basis of affinity
alone.
Interaction of the SKN-1 amino-terminal arm with DNA.
Our
experiments indicate that models for how the Skn domain amino-terminal
arm interacts with DNA must account for the AT-rich sequence
specificity mediated by the arm and for the involvement of multiple
amino acid residues within the arm in binding. The models must also
explain how binding of the arm apparently affects DNA conformation,
which was suggested by the observation that prior hydroxyl radical
cleavage adjacent to the AT-rich element enhanced binding by the Skn
domain but not by
1-9 (Fig. 1B) (8). Supporting the idea
that specification of the AT-rich element may involve indirect
mechanisms, these cleavage experiments did not identify individual
bases within this region that are specifically required for binding of
the arm (8), and each individual base pair made a comparably
modest contribution to binding by the
1-7 mutant, in which the arm
is truncated (Fig. 9A and B, lanes 9, 27, 33, and 39). Models for
binding of the amino-terminal arm to DNA should also account for the
importance of the AT-rich element minor groove, which was indicated by
hydroxyl radical footprinting, the I · C substitution
experiments, and the methylation interference assay (2)
(Fig. 1B and 6). Finally, the locations of the arm and the adjacent
helix 1 (Fig. 1A) in the Skn domain crystal structure (Fig. 1C)
(32) provide an additional caveat, because they indicate that a major conformational adaptation would be required if the arm is
oriented analogously to homeodomain amino-terminal arms (Fig. 1B) and
lies deeply in the AT-rich element minor groove.
In light of the propensity of A · T base pairs to bend toward
the minor groove, one plausible model by which the AT-rich element
minor groove might be important for a conformational effect is
that it
allows the arm to promote a DNA bend or kink. However,
our experiments
suggest that the Skn domain arm does not promote
DNA bending but also
that the Skn domain BR and support segment
induce a modest DNA bend
that should increase the surface area
along which SKN-1 interacts with
DNA (
32). Various assays have
indicated that some related
bZIP proteins bend DNA (
16,
21,
30,
40), but this issue has
remained controversial (
12,
28,
36,
37). However, our
evidence comes from both gel-based
(circular-permutation) and solution
(circularization kinetics)
assays and is in general agreement with
crystallographic data
(
32). An effect of DNA bending or
conformation on SKN-1 binding
may be important because transcription
factors generally function
within multiprotein complexes, the
composition of which can be
influenced by subtle intermolecular
interactions and effects on
DNA conformation (
7). In
addition, SKN-1 activity in vivo is
modulated by the POP-1 protein, a
high-mobility-group protein
of the TCF (TCF/LEF) family
(
25), members of which are both
Wnt signalling targets and
"architectural" proteins that bend
DNA (
5,
9).
A model that is consistent with the experimental evidence is that the
amino-terminal arm interacts with the DNA backbone around
position

4
and that it lies above or across the minor groove,
as suggested by the
hydroxyl radical protection footprint (Fig.
1B and C). In doing so, it
induces a localized conformational
effect that is favored by the
AT-rich element minor groove (
29,
39) and makes multiple
interactions with the DNA, including
some that are unstable. These
interactions help discriminate against
G · C base pairs in this
region, and some may directly involve
bases in the distal portion of
the AT-rich element. The data also
do not rule out a more extensive
direct interaction with the AT-rich
element minor groove. However, that
model would require the arm
to be oriented more similarly to those of
homeodomains (Fig.
1B)
and is more difficult to reconcile with the Skn
domain crystal
structure (Fig.
1C) (
32). Further structural
investigations
will be necessary to determine exactly how the arm
specifies the
AT-rich element as it interacts with DNA. However, our
experiments
illustrate how mutagenesis and biochemical analyses can
complement
and extend structural studies and how short polypeptide
segments
that are relatively unstructured can make important
contributions
to binding
specificity.
 |
ACKNOWLEDGMENTS |
We thank Tom Ellenberger, David Fisher, Phil Auron, and members
of the Blackwell lab for helpful discussions and critically reading the
manuscript, and we thank Karen Kim for help with sequencing. For
protein purification we thank Dara Gilbert, Jim Cheung, and Tom
Ellenberger, whom we also thank for computer graphics.
This work was supported by a grant from the NIH (GM50900) to T.K.B.,
who is a Searle Scholar.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Center for Blood
Research, Harvard Medical School, Boston, MA 02115. Phone: (617)
278-3150. Fax: (617) 278-3131. E-mail:
blackwell{at}cbr.med.harvard.edu.
 |
REFERENCES |
| 1.
|
Billeter, M.,
Y. Q. Qian,
G. Otting,
M. Muller,
W. Gehring, and K. Wuthrich.
1993.
Determination of the nuclear magnetic resonance solution structure of an Antennapedia homeodomain-DNA complex.
J. Mol. Biol.
234:1084-1093[Medline].
|
| 2.
|
Blackwell, T. K.,
B. Bowerman,
J. Priess, and H. Weintraub.
1994.
Formation of a monomeric DNA binding domain by Skn-1 bZIP and homeodomain elements.
Science
266:621-628[Abstract/Free Full Text].
|
| 3.
|
Bowerman, B.,
B. W. Draper,
C. Mello, and J. Priess.
1993.
The maternal gene skn-1 encodes a protein that is distributed unequally in early C. elegans embryos.
Cell
74:443-452[Medline].
|
| 4.
|
Bowerman, B.,
B. A. Eaton, and J. R. Priess.
1992.
skn-1, a maternally expressed gene required to specify the fate of ventral blastomeres in the early C. elegans embryo.
Cell
68:1061-1075[Medline].
|
| 5.
|
Cadigan, K. M., and R. Nusse.
1997.
Wnt signaling: a common theme in animal development.
Genes Dev.
11:3286-3305[Free Full Text].
|
| 6.
|
Carey, J.
1991.
Gel retardation.
Methods Enzymol.
208:103-117[Medline].
|
| 7.
|
Carey, M.
1998.
The enhanceosome and transcriptional synergy.
Cell
92:5-8[Medline].
|
| 8.
|
Carroll, A. S.,
D. E. Gilbert,
X. Liu,
J. W. Cheung,
J. E. Michnowicz,
G. Wagner,
T. E. Ellenberger, and T. K. Blackwell.
1997.
SKN-1 domain folding and basic region monomer stabilization upon DNA binding.
Genes Dev.
11:2227-2238[Abstract/Free Full Text].
|
| 9.
|
Clevers, H., and M. van de Wetering.
1997.
TCF/LEF factor earn their wings.
Trends Genet.
13:485-489[Medline].
|
| 10.
|
Feng, J.-A.,
R. C. Johnson, and R. E. Dickerson.
1994.
Hin recombinase bound to DNA: the origin of specificity in major and minor groove interactions.
Science
263:348-355[Abstract/Free Full Text].
|
| 11.
|
Furukubo-Tokunaga, K.,
S. Flister, and W. J. Gehring.
1993.
Functional specificity of the Antennapedia homeodomain.
Proc. Natl. Acad. Sci. USA
90:6360-6364[Abstract/Free Full Text].
|
| 12.
|
Hagerman, P. J.
1996.
Do basic region-leucine zipper proteins bend their DNA targets ... does it matter?
Proc. Natl. Acad. Sci. USA
93:9993-9996[Abstract/Free Full Text].
|
| 13.
|
Hockings, S. C.,
J. D. Kahn, and D. M. Crothers.
1998.
Characterization of the ATF/CREB site and its complex with GCN4.
Proc. Natl. Acad. Sci. USA
95:1410-1415[Abstract/Free Full Text].
|
| 14.
|
Jacobson, E. M.,
P. Li,
A. Leon-del-Rio,
M. G. Rosenfeld, and A. K. Aggarwal.
1997.
Structure of Pit-1 POU domain bound to DNA as a dimer:unexpected arrangement and flexibility.
Genes Dev.
11:198-212[Abstract/Free Full Text].
|
| 15.
|
Kahn, J. D., and D. M. Crothers.
1992.
Protein-induced bending and DNA cyclization.
Proc. Natl. Acad. Sci. USA
89:6343-6347[Abstract/Free Full Text].
|
| 16.
|
Kerppola, T. K., and T. Curran.
1991.
Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity.
Cell
66:317-326[Medline].
|
| 17.
|
Kissinger, C. R.,
B. Liu,
E. Martin-Blanco,
T. B. Kornberg, and C. Pabo.
1990.
Crystal structure of an engrailed homeodomain-DNA complex at 2.8 Å resolution: a framework for understanding homeodomain-DNA interactions.
Cell
63:579-580[Medline].
|
| 18.
|
Klemm, J. D.,
M. A. Rould,
R. Aurora,
W. Herr, and C. O. Pabo.
1994.
Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules.
Cell
77:21-32[Medline].
|
| 19.
|
Konig, P.,
R. Giraldo,
L. Chapman, and D. Rhodes.
1996.
The crystal structure of the DNA-binding domain of yeast RAP1 in complex with telomeric DNA.
Cell
85:125-136[Medline].
|
| 20.
|
Krebs, D.,
B. Dahmani,
S. El Antri,
M. Monnot,
O. Convert,
O. Mauffret,
F. Troalen, and S. Fermandjian.
1995.
The basic subdomain of the c-Jun oncoprotein: a joint CD, Fourier-transform infrared and NMR study.
Eur. J. Biochem.
231:370-380[Medline].
|
| 21.
|
Leonard, D. A.,
N. Rajaram, and T. K. Kerppola.
1997.
Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
Proc. Natl. Acad. Sci. USA
94:4913-4918[Abstract/Free Full Text].
|
| 22.
|
Li, P.,
X. He,
M. R. Gerrero,
M. Mok,
A. Aggarwal, and M. G. Rosenfeld.
1993.
Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors.
Genes Dev.
7:2483-2496[Abstract/Free Full Text].
|
| 23.
|
Li, T.,
M. R. Stark,
A. D. Johnson, and C. Wolberger.
1995.
Crystal structure of the MATa1/MAT alpha 2 homeodomain heterodimer bound to DNA.
Science
270:262-269[Abstract/Free Full Text].
|
| 24.
|
Lin, L., and W. McGinnis.
1992.
Mapping functional specificity in the Dfd and Ubx homeo domains.
Genes Dev.
6:1071-1081[Abstract/Free Full Text].
|
| 25.
|
Lin, R.,
S. Thompson, and J. R. Priess.
1995.
pop-1 encodes an HMG box protein required for the specification of a mesoderm precursor in early C. elegans embryos.
Cell
83:599-609[Medline].
|
| 26.
|
Lo, M.-C.,
S. Ha,
I. Pelczer,
S. Pal, and S. Walker.
1998.
The solution structure of the DNA binding domain of Skn-1.
Proc. Natl. Acad. Sci. USA
95:8455-8460[Abstract/Free Full Text].
|
| 27.
|
McCormick, R. J. X.,
T. Badalian, and D. E. Fisher.
1996.
The leucine zipper may induce electrophoretic mobility anomalies without DNA bending.
Proc. Natl. Acad. Sci. USA
93:14434-14439[Abstract/Free Full Text].
|
| 28.
|
McGill, G., and D. E. Fisher.
1998.
DNA bending and the curious case of Fos/Jun.
Chem. Biol.
5:R29-R38[Medline].
|
| 29.
|
Pabo, C. O., and R. T. Sauer.
1992.
Transcription factors: structural families and principles of DNA recognition.
Annu. Rev. Biochem.
61:1053-1095[Medline].
|
| 30.
|
Paolella, D. N.,
C. R. Palmer, and A. Schepartz.
1994.
DNA targets for certain bZIP proteins distinguished by an intrinsic bend.
Science
264:1130-1133[Abstract/Free Full Text].
|
| 31.
|
Puglisi, J. D.,
L. Chen,
S. Blanchard, and A. D. Frankel.
1995.
Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex.
Science
270:1200-1203[Abstract/Free Full Text].
|
| 32.
|
Rupert, P. B.,
G. W. Daughdrill,
B. Bowerman, and B. W. Matthews.
1998.
The binding domain of Skn-1 in complex with DNA: a new DNA-binding motif.
Nat. Struct. Biol.
5:484-491[Medline].
|
| 33.
|
Saudek, V.,
H. S. Pasley,
T. Gibson,
H. Gausepohl,
R. Frank, and A. Pastore.
1991.
Solution structure of the basic region from the transcriptional activator GCN4.
Biochemistry
30:1310-1317[Medline].
|
| 34.
|
Scott, M. P.,
J. W. Tamkun, and G. W. I. Hartzell.
1989.
The structure and function of the homeodomain.
Biochim. Biophys. Acta
989:25-48[Medline].
|
| 35.
|
Shang, Z.,
V. E. Issaac,
H. Li,
L. Patel,
K. M. Catron,
T. Curran,
G. T. Montelione, and C. Abate.
1994.
Design of a "minimAl" homeodomain: the N-terminal arm modulates DNA binding affinity and stabilizes homeodomain structure.
Proc. Natl. Acad. Sci. USA
91:8373-8377[Abstract/Free Full Text].
|
| 36.
|
Sitlani, A., and D. M. Crothers.
1998.
DNA-binding domains of Fos and Jun do not induce DNA curvature: an investigation with solution and gel methods.
Proc. Natl. Acad. Sci. USA
95:1404-1409[Abstract/Free Full Text].
|
| 37.
|
Sitlani, A., and D. M. Crothers.
1996.
Fos and Jun do not bend the AP-1 recognition site.
Proc. Natl. Acad. Sci. USA
93:3248-3252[Abstract/Free Full Text].
|
| 38.
|
Spolar, R. S., and M. T. Record, Jr.
1994.
Coupling of local folding to site-specific binding of proteins to DNA.
Science
263:777-784[Abstract/Free Full Text].
|
| 39.
|
Steitz, T. A.
1990.
Structural studies of protein-nucleic acid interaction: the sources of sequence-specific binding.
Q. Rev. Biophys.
23:205-280[Medline].
|
| 40.
|
Strauss-Soukup, J. K., and L. J. Maher.
1997.
DNA bending by GCN4 mutants bearing cationic residues.
Biochemistry
36:10026-10032[Medline].
|
| 41.
|
Treacy, M. N.,
L. I. Neilson,
E. E. Turner,
X. He, and M. G. Rosenfeld.
1992.
Twin of I-POU: a two amino acid difference in the I-POU homeodomain distinguishes an activator from an inhibitor of transcription.
Cell
68:491-505[Medline].
|
| 42.
|
Weiss, M. A.
1990.
Thermal unfolding studies of a leucine zipper domain and its specific DNA complex: implications for scissors grip recognition.
Biochemistry
29:8020-8024[Medline].
|
| 43.
|
Wilson, D. S.,
B. Guenther,
C. Desplan, and J. Kuriyan.
1995.
High resolution crystal structure of a paired (Pax) class cooperative homeodomain dimer on DNA.
Cell
82:709-719[Medline].
|
| 44.
|
Wolberger, C.,
A. K. Vershon,
B. Liu,
A. D. Johnson, and C. O. Pabo.
1991.
Crystal structure of a MAT 2 homeodomain-operator complex suggests a general model for homeodomain-DNA interactions.
Cell
67:517-528[Medline].
|
| 45.
|
Wright, D. A.,
B. Futcher,
P. Ghosh, and R. S. Geha.
1996.
Association of human fas (CD95) with a ubiquitin-conjugating enzyme (UBC-FAP).
J. Biol. Chem.
271:31037-31043[Abstract/Free Full Text].
|
| 46.
|
Wu, H.-M., and D. M. Crothers.
1984.
The locus of sequence-directed and protein-induced DNA bending.
Nature
308:509-513[Medline].
|
| 47.
|
Zeng, W.,
D. J. Andrew,
L. D. Mathies,
M. A. Horner, and M. P. Scott.
1993.
Ectopic expression and function of the Antp and Scr homeotic genes: the N terminus of the homeodomain is critical to functional specificity.
Development
118:339-352[Abstract].
|
| 48.
|
Zhang, H.,
K. M. Catron, and C. Abate-Shen.
1996.
A role for the Msx-1 homeodomain in transcriptional regulation: residues in the N-terminal arm mediate TATA binding protein interaction and transcriptional repression.
Proc. Natl. Acad. Sci. USA
93:1764-1769[Abstract/Free Full Text].
|
| 49.
|
Zhu, J.,
R. J. Hill,
P. J. Heid,
M. Fukuyama,
A. Sugimoto,
J. R. Priess, and J. H. Rothman.
1997.
end-1 encodes an apparent GATA factor that specifies the endoderm precursor in Caenorhabditis elegans embryos.
Genes Dev.
11:2883-2896[Abstract/Free Full Text].
|
Molecular and Cellular Biology, April 1999, p. 3039-3050, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
An, J. H., Blackwell, T. K.
(2003). SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev.
17: 1882-1893
[Abstract]
[Full Text]
-
Pedley, K. F., Walton, J. D.
(2001). Regulation of cyclic peptide biosynthesis in a plant pathogenic fungus by a novel transcription factor. Proc. Natl. Acad. Sci. USA
10.1073/pnas.231491298v1
[Abstract]
[Full Text]
-
Kophengnavong, T., Michnowicz, J. E., Blackwell, T. K.
(2000). Establishment of Distinct MyoD, E2A, and Twist DNA Binding Specificities by Different Basic Region-DNA Conformations. Mol. Cell. Biol.
20: 261-272
[Abstract]
[Full Text]
-
Walker, A. K., See, R., Batchelder, C., Kophengnavong, T., Gronniger, J. T., Shi, Y., Blackwell, T. K.
(2000). A Conserved Transcription Motif Suggesting Functional Parallels between Caenorhabditis elegans SKN-1 and Cap`n'Collar-related Basic Leucine Zipper Proteins. J. Biol. Chem.
275: 22166-22171
[Abstract]
[Full Text]
-
Yoo, J.-Y., Wang, W., Desiderio, S., Nathans, D.
(2001). Synergistic Activity of STAT3 and c-Jun at a Specific Array of DNA Elements in the alpha 2-Macroglobulin Promoter. J. Biol. Chem.
276: 26421-26429
[Abstract]
[Full Text]
-
Pedley, K. F., Walton, J. D.
(2001). Regulation of cyclic peptide biosynthesis in a plant pathogenic fungus by a novel transcription factor. Proc. Natl. Acad. Sci. USA
98: 14174-14179
[Abstract]
[Full Text]